(Q21260310)

English

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

scientific article

In more languages

Statements

scholarly article

0 references

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia (English)

0 references

0 references

multicenter clinical trial

0 references

0 references

author name string

David H Adams

1

author given names

David H

author last names

Adams

1 reference

Dimensions Publication ID

19 August 2022

Bruce J Kinon

2

author given names

Bruce J

author last names

Kinon

1 reference

Dimensions Publication ID

19 August 2022

Simin Baygani

3

author given names

Simin

author last names

Baygani

1 reference

Dimensions Publication ID

19 August 2022

Brian A Millen

4

author given names

Brian A

author last names

Millen

1 reference

Dimensions Publication ID

19 August 2022

Isabella Velona

5

author given names

Isabella

author last names

Velona

1 reference

Dimensions Publication ID

19 August 2022

Sara Kollack-Walker

6

author given names

Sara

author last names

Kollack-Walker

1 reference

Dimensions Publication ID

19 August 2022

David P Walling

7

author given names

David P

author last names

Walling

1 reference

Dimensions Publication ID

19 August 2022

language of work or name

0 references

publication date

22 May 2013

0 references

1 reference

13

0 references

1

0 references

143

0 references

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3666887

19 March 2017

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3666887

19 March 2017

A rating scale for drug-induced akathisia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3666887

19 March 2017

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1186/1471-244X-13-143

22 April 2017

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxyli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3666887

12 September 2017

Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3666887

12 September 2017

A rating scale for extrapyramidal side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3666887

30 May 2018

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-143

21 January 2018

The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23694720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-13-143

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

release_77pwov63izfhhkwxma3kpagx7m

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21260310&oldid=2176722794"